Targeting the Muscarinic M1 Receptor With a Selective, Brain-Penetrant Antagonist to Promote Remyelination in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Proceedings of the National Academy of Sciences of the United States of America
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis
Proc. Natl. Acad. Sci. U.S.A 2024 Aug 06;121(32)e2407974121, MM Poon, KI Lorrain, KJ Stebbins, GC Edu, AR Broadhead, AJ Lorenzana, JR Roppe, JM Baccei, CS Baccei, AC Chen, AJ Green, DS Lorrain, JR ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.